Adults aged ≥50 years boosted with SARS-CoV-2 mRNA vaccines less likely to experience adverse reactions after second booster than during initial booster

Adults aged ≥50 years boosted with SARS-CoV-2 mRNA vaccines less likely to experience adverse reactions after second booster than during initial booster
Everything Covid-19 - cover
Magazine
Avatar

Birgit flipped this story into Everything Covid-1966d

More stories from COVID-19 Vaccines

More stories from MRNA

More stories from Vaccination